» Articles » PMID: 38963534

Obturator Prostheses with Intramucosal Retention System in Patients with Maxillectomy

Abstract

Purpose: To evaluate the intramucosal retention system in patients' masticatory efficiency and quality of life in this case series.

Material And Methods: A total of 3 individuals with maxillectomy were included for rehabilitation with a complete obturator prostheses with an intramucosal retention system (OPI). The complete obturator prostheses was made for 60 days, and electromyography assessments and bite force were applied before, after 30, 60, and 90 days of surgery and prostheses installation. The University of Washington Quality of Life Questionnaire (UW-QoL) and the Obturator Functional Scale (OFS) were also administered at baseline and in the same follow-up periods. The electromyography was evaluated on both sides of the masseter, temporalis, and buccinator muscles while chewing hard and soft food. The maximum bite force was recorded in the central incisors and both sides of the first molar region.

Results: Bite force values increased in the first molar region, and muscular electrical activity remained constant. Items related to the taste and swallowing of the UW-QOL impacted. Most OFS questionnaire data responses indicated that patients improved in swallowing liquid foods and appearance.

Conclusions: The rehabilitative capacity improves masticatory efficiency and QoL in adults maxilectomized and rehabilitated with OPI analysis in the study. Further clinical studies should be encouraged to determine the effectiveness of this retentive system.

References
1.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

2.
Panarese I, Aquino G, Ronchi A, Longo F, Montella M, Cozzolino I . Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route. Expert Rev Anticancer Ther. 2018; 19(2):105-119. DOI: 10.1080/14737140.2019.1561288. View

3.
Shi H, Ng C, Kwa C, Sim Q . Ameloblastoma: A succinct review of the classification, genetic understanding and novel molecular targeted therapies. Surgeon. 2020; 19(4):238-243. DOI: 10.1016/j.surge.2020.06.009. View

4.
Cramer J, Burtness B, Le Q, Ferris R . The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019; 16(11):669-683. DOI: 10.1038/s41571-019-0227-z. View

5.
Artopoulou I, Sarafianou A, Perisanidis C, Polyzois G . Effectiveness of prosthetic rehabilitation and quality of life of older edentulous head and neck cancer survivors following resection of the maxilla: a cross-sectional study. Support Care Cancer. 2022; 30(5):4111-4120. DOI: 10.1007/s00520-022-06850-9. View